Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder

Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder

US Patent 10111888 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intranasal lower dosage strength testosterone gel formulations and use thereof f2020
Intranasal lower dosage strength testosterone gel formulations and use thereof f2020
Intranasal lower dosage strength testosterone gel formulations and use thereof f2020
Intranasal lower dosage strength testosterone gel formulations and use thereof f2020
Use of a photosynthetic cell extract comprising functional thylakoids in cosmeti2020
Use of a photosynthetic cell extract comprising functional thylakoids in cosmeti2018
Cyclodextrin and budesonide derivative compositions and methods2018
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testoste2017
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testoste2017
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testoste2017
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testoste2017
Modified release formulations of a bupropion salt2016